PhRMA has recently promulgated new guidelines for members on responsible direct-to-consumer advertising, and one of the principles states that any DTC ads should be submitted for FDA review prior to dissemination. (See "The New Economics of DTC: Responsibility Sells," The RPM Report, April 2006 Also see "The New Economics of DTC: Responsibility Sells" - Pink Sheet, 1 April, 2006..)
There is only one problem: who is going to review all of those ads at FDA? Right now the agency...




